↓ Skip to main content

The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications

Overview of attention for article published in Frontiers in oncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
twitter
3 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications
Published in
Frontiers in oncology, September 2019
DOI 10.3389/fonc.2019.00852
Pubmed ID
Authors

Xi Chen, Zhijie Xu, Shuangshuang Zeng, Xiang Wang, Wanli Liu, Long Qian, Jie Wei, Xue Yang, Qiuying Shen, Zhicheng Gong, Yuanliang Yan

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 13%
Student > Master 4 10%
Researcher 4 10%
Student > Ph. D. Student 3 8%
Other 2 5%
Other 3 8%
Unknown 18 46%
Readers by discipline Count As %
Chemistry 5 13%
Medicine and Dentistry 4 10%
Biochemistry, Genetics and Molecular Biology 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Business, Management and Accounting 1 3%
Other 4 10%
Unknown 19 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2022.
All research outputs
#2,598,536
of 25,774,185 outputs
Outputs from Frontiers in oncology
#618
of 22,796 outputs
Outputs of similar age
#51,306
of 351,525 outputs
Outputs of similar age from Frontiers in oncology
#25
of 391 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,796 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,525 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 391 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.